The market performance of G1 Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $5.00 on 02/08/24, with the lowest value for the same timeframe being $1.08, recorded on 10/09/23.
52-week price history of GTHX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. G1 Therapeutics Inc’s current trading price is -14.40% away from its 52-week high, while its distance from the 52-week low is 296.30%. The stock’s price range for this period has remained between $1.08 and $5.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.69 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.38 million over the last three months.
Financial Performance and Market Capitalization
G1 Therapeutics Inc (GTHX) has experienced a quarterly rise of 24.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 223.42M and boasts a workforce of 100 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.38, with a change in price of +2.65. Similarly, G1 Therapeutics Inc recorded 1,530,741 in trading volume during the last 100 days, posting a change of +162.58%.
GTHX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GTHX stands at 1.62. Similarly, the long-term debt-to-equity ratio is also 1.58.
GTHX Stock Stochastic Average
As of today, the raw stochastic average of G1 Therapeutics Inc over the last 50 days is at 75.92%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 63.72%. Further, the company’s Stochastic %K and %D values for the last 20 days were 62.53% and 70.61%, respectively.
GTHX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded an increase of 40.33%. However, over the last six months, the performance has been weaker by 256.67%. The price of GTHX increased 33.33% over the last 30 days. And in the last five days, it has fallen by -7.96%.
